Re-Purposing the Ordering of 'Routine' Laboratory Tests in Hospitalized Medical Patients (RePORT Study)
NCT ID: NCT06119464
Last Updated: 2024-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
251817 participants
INTERVENTIONAL
2023-01-02
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this research study is the following:
1. To implement a multimodal intervention bundle containing healthcare provider and patient engagement tools for hospitalized medical inpatients in 14 hospitals across the province of Alberta in Canada using a cluster randomized stepped-wedge design
2. To evaluate the impact of the intervention bundle on laboratory test utilization of six target laboratory tests (complete blood count, electrolytes, creatinine, urea, partial thromboplastin time, and international normalized ratio), costs, and patient safety outcomes.
This intervention bundle will be implemented across all the adult hospital sites in Alberta starting January 2023 and evaluated until October 2024.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unexposed to intervention (control period)
This is the time period of the study where hospital clusters are not receiving the intervention
No interventions assigned to this group
Exposed to intervention (intervention period)
This is the time period of the study where hospital clusters are receiving the multimodal intervention.
Multimodal Intervention: Education
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: Audit and Feedback
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: Patient Engagement
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: System Changes
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Intervention: Education
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: Audit and Feedback
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: Patient Engagement
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Multimodal Intervention: System Changes
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hospitals not enrolled
* non-medical units (eg. ICU, surgical, pediatric, obstetrical units)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alberta Health services
OTHER
University of British Columbia
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anshula Ambasta
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anshula Ambasta
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Calgary
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB17-1215
Identifier Type: -
Identifier Source: org_study_id